Advisor Group Holdings, Inc. Harrow Health, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 21,782 shares of HROW stock, worth $655,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,782

Previous 16,307 33.57%

Holding current value

$655,420

Previous $547,000 5.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$22.22 - $36.67 $121,654 - $200,768	5,475 Added 33.57%	21,782 $579,000
Q4 2024 Feb 07, 2025	BUY	$33.39 - $57.5 $834 - $1,437	25 Added 0.15%	16,307 $547,000
Q3 2024 Nov 13, 2024	SELL	$20.85 - $46.47 $3,794 - $8,457	-182 Reduced 1.11%	16,282 $732,000
Q2 2024 Aug 13, 2024	BUY	$10.0 - $21.64 $146,260 - $316,506	14,626 Added 795.76%	16,464 $343,000
Q1 2024 May 10, 2024	BUY	$9.3 - $13.23 $15,168 - $21,578	1,631 Added 787.92%	1,838 $24,000
Q4 2023 Feb 12, 2024	SELL	$8.1 - $16.36 $4,698 - $9,488	-580 Reduced 73.7%	207 $2,000
Q3 2023 Nov 13, 2023	SELL	$14.03 - $22.08 $30,515 - $48,023	-2,175 Reduced 73.43%	787 $11,000
Q2 2023 Aug 10, 2023	SELL	$17.37 - $28.08 $1.1 Million - $1.77 Million	-63,150 Reduced 95.52%	2,962 $56,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $492,288 - $763,332	35,570 Added 116.46%	66,112 $1.4 Million
Q4 2022 Feb 10, 2023	BUY	$10.28 - $14.78 $24,260 - $34,880	2,360 Added 8.37%	30,542 $450,000
Q2 2022 Aug 10, 2022	BUY	$5.75 - $7.74 $161,143 - $216,913	28,025 Added 17850.32%	28,182 $205,000
Q1 2022 May 04, 2022	SELL	$6.77 - $8.66 $33,051 - $42,278	-4,882 Reduced 96.88%	157 $1.18 Million
Q3 2021 Nov 05, 2021	SELL	$6.99 - $10.6 $43,841 - $66,483	-6,272 Reduced 55.45%	5,039 $46,000
Q2 2021 Aug 02, 2021	BUY	$6.68 - $11.07 $24,488 - $40,582	3,666 Added 47.95%	11,311 $105,000
Q1 2021 May 13, 2021	BUY	$6.26 - $11.03 $1,489 - $2,625	238 Added 3.21%	7,645 $52,000
Q4 2020 Feb 10, 2021	SELL	$4.76 - $6.93 $71 - $103	-15 Reduced 0.2%	7,407 $51,000
Q3 2020 Nov 12, 2020	SELL	$4.71 - $7.36 $3,264 - $5,100	-693 Reduced 8.54%	7,422 $41,000
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $2,591 - $4,645	-718 Reduced 8.13%	8,115 $43,000
Q1 2020 May 18, 2020	BUY	$3.5 - $7.31 $30,915 - $64,569	8,833 New	8,833 $36,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.1M

Call Options Held

330K

Put Options Held

670K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $815M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Harrow Health, Inc. Transaction History